Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Adapting to Space Limitations During Prone Real-Time Magnetic Resonance Imaging-Guided Stereotaxic Laser Ablation: Technical Pearls.

Zervos TM, Scarpace L, Robin AM, Schwalb JM, Air EL.

Oper Neurosurg (Hagerstown). 2019 Jun 27. pii: opz173. doi: 10.1093/ons/opz173. [Epub ahead of print]

PMID:
31245819
2.

MR-guided laser interstitial thermal therapy in the treatment of recurrent intracranial meningiomas.

Rammo R, Scarpace L, Nagaraja T, Lee I.

Lasers Surg Med. 2019 Mar;51(3):245-250. doi: 10.1002/lsm.23045. Epub 2018 Dec 28.

PMID:
30592538
3.

The safety of magnetic resonance imaging-guided laser interstitial thermal therapy for cerebral radiation necrosis.

Rammo R, Asmaro K, Schultz L, Scarpace L, Siddiqui S, Walbert T, Kalkanis S, Lee I.

J Neurooncol. 2018 Jul;138(3):609-617. doi: 10.1007/s11060-018-2828-2. Epub 2018 Mar 13.

PMID:
29536345
4.

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, Zheng S, Chang E, Gabriel Sauvé CE, Olar A, Lan ZD, Finocchiaro G, Phillips JJ, Berger MS, Gabrusiewicz KR, Wang G, Eskilsson E, Hu J, Mikkelsen T, DePinho RA, Muller F, Heimberger AB, Sulman EP, Nam DH, Verhaak RGW.

Cancer Cell. 2018 Jan 8;33(1):152. doi: 10.1016/j.ccell.2017.12.012. No abstract available.

5.

Intraoperative Raman Spectroscopy.

Brusatori M, Auner G, Noh T, Scarpace L, Broadbent B, Kalkanis SN.

Neurosurg Clin N Am. 2017 Oct;28(4):633-652. doi: 10.1016/j.nec.2017.05.014. Epub 2017 Aug 10. Review.

PMID:
28917291
6.

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, Zheng S, Chang E, Sauvé CG, Olar A, Lan ZD, Finocchiaro G, Phillips JJ, Berger MS, Gabrusiewicz KR, Wang G, Eskilsson E, Hu J, Mikkelsen T, DePinho RA, Muller F, Heimberger AB, Sulman EP, Nam DH, Verhaak RGW.

Cancer Cell. 2017 Jul 10;32(1):42-56.e6. doi: 10.1016/j.ccell.2017.06.003. Erratum in: Cancer Cell. 2018 Jan 8;33(1):152.

7.

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Sabedot TS, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T Jr, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J, Gehlenborg N, Haussler D, Heiman DI, Iype L, Jacobsen A, Ju Z, Katzman S, Kim H, Knijnenburg T, Kreisberg RB, Lawrence MS, Lee W, Leinonen K, Lin P, Ling S, Liu W, Liu Y, Liu Y, Lu Y, Mills G, Ng S, Noble MS, Paull E, Rao A, Reynolds S, Saksena G, Sanborn Z, Sander C, Schultz N, Senbabaoglu Y, Shen R, Shmulevich I, Sinha R, Stuart J, Sumer SO, Sun Y, Tasman N, Taylor BS, Voet D, Weinhold N, Weinstein JN, Yang D, Yoshihara K, Zheng S, Zhang W, Zou L, Abel T, Sadeghi S, Cohen ML, Eschbacher J, Hattab EM, Raghunathan A, Schniederjan MJ, Aziz D, Barnett G, Barrett W, Bigner DD, Boice L, Brewer C, Calatozzolo C, Campos B, Carlotti CG Jr, Chan TA, Cuppini L, Curley E, Cuzzubbo S, Devine K, DiMeco F, Duell R, Elder JB, Fehrenbach A, Finocchiaro G, Friedman W, Fulop J, Gardner J, Hermes B, Herold-Mende C, Jungk C, Kendler A, Lehman NL, Lipp E, Liu O, Mandt R, McGraw M, Mclendon R, McPherson C, Neder L, Nguyen P, Noss A, Nunziata R, Ostrom QT, Palmer C, Perin A, Pollo B, Potapov A, Potapova O, Rathmell WK, Rotin D, Scarpace L, Schilero C, Senecal K, Shimmel K, Shurkhay V, Sifri S, Singh R, Sloan AE, Smolenski K, Staugaitis SM, Steele R, Thorne L, Tirapelli DP, Unterberg A, Vallurupalli M, Wang Y, Warnick R, Williams F, Wolinsky Y, Bell S, Rosenberg M, Stewart C, Huang F, Grimsby JL, Radenbaugh AJ, Zhang J.

N Engl J Med. 2015 Jun 25;372(26):2481-98. doi: 10.1056/NEJMoa1402121. Epub 2015 Jun 10.

8.

Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.

Kim H, Zheng S, Amini SS, Virk SM, Mikkelsen T, Brat DJ, Grimsby J, Sougnez C, Muller F, Hu J, Sloan AE, Cohen ML, Van Meir EG, Scarpace L, Laird PW, Weinstein JN, Lander ES, Gabriel S, Getz G, Meyerson M, Chin L, Barnholtz-Sloan JS, Verhaak RG.

Genome Res. 2015 Mar;25(3):316-27. doi: 10.1101/gr.180612.114. Epub 2015 Feb 3.

9.

Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients.

Nicolasjilwan M, Hu Y, Yan C, Meerzaman D, Holder CA, Gutman D, Jain R, Colen R, Rubin DL, Zinn PO, Hwang SN, Raghavan P, Hammoud DA, Scarpace LM, Mikkelsen T, Chen J, Gevaert O, Buetow K, Freymann J, Kirby J, Flanders AE, Wintermark M; TCGA Glioma Phenotype Research Group.

J Neuroradiol. 2015 Jul;42(4):212-21. doi: 10.1016/j.neurad.2014.02.006. Epub 2014 Jul 2.

10.

Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.

Jain R, Poisson LM, Gutman D, Scarpace L, Hwang SN, Holder CA, Wintermark M, Rao A, Colen RR, Kirby J, Freymann J, Jaffe CC, Mikkelsen T, Flanders A.

Radiology. 2014 Aug;272(2):484-93. doi: 10.1148/radiol.14131691. Epub 2014 Mar 19.

11.

Machine-based morphologic analysis of glioblastoma using whole-slide pathology images uncovers clinically relevant molecular correlates.

Kong J, Cooper LA, Wang F, Gao J, Teodoro G, Scarpace L, Mikkelsen T, Schniederjan MJ, Moreno CS, Saltz JH, Brat DJ.

PLoS One. 2013 Nov 13;8(11):e81049. doi: 10.1371/journal.pone.0081049. eCollection 2013.

12.

Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.

Rutledge WC, Kong J, Gao J, Gutman DA, Cooper LA, Appin C, Park Y, Scarpace L, Mikkelsen T, Cohen ML, Aldape KD, McLendon RE, Lehman NL, Miller CR, Schniederjan MJ, Brennan CW, Saltz JH, Moreno CS, Brat DJ.

Clin Cancer Res. 2013 Sep 15;19(18):4951-60. doi: 10.1158/1078-0432.CCR-13-0551. Epub 2013 Jul 17.

13.

The Corpus Callosum Wallerian Degeneration in the Unilateral Brain Tumors: Evaluation with Diffusion Tensor Imaging (DTI).

Saksena S, Jain R, Schultz L, Jiang Q, Soltanian-Zadeh H, Scarpace L, Rosenblum M, Mikkelsen T, Nazem-Zadeh MR.

J Clin Diagn Res. 2013 Feb;7(2):320-5. doi: 10.7860/JCDR/2013/4491.2757. Epub 2013 Feb 1.

14.

Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.

Jain R, Narang J, Griffith B, Bagher-Ebadian H, Scarpace L, Mikkelsen T, Littenberg B, Schultz LR.

Acad Radiol. 2013 Apr;20(4):478-85. doi: 10.1016/j.acra.2012.11.011.

PMID:
23498990
15.

MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set.

Gutman DA, Cooper LA, Hwang SN, Holder CA, Gao J, Aurora TD, Dunn WD Jr, Scarpace L, Mikkelsen T, Jain R, Wintermark M, Jilwan M, Raghavan P, Huang E, Clifford RJ, Mongkolwat P, Kleper V, Freymann J, Kirby J, Zinn PO, Moreno CS, Jaffe C, Colen R, Rubin DL, Saltz J, Flanders A, Brat DJ.

Radiology. 2013 May;267(2):560-9. doi: 10.1148/radiol.13120118. Epub 2013 Feb 7.

16.

Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers.

Jain R, Poisson L, Narang J, Gutman D, Scarpace L, Hwang SN, Holder C, Wintermark M, Colen RR, Kirby J, Freymann J, Brat DJ, Jaffe C, Mikkelsen T.

Radiology. 2013 Apr;267(1):212-20. doi: 10.1148/radiol.12120846. Epub 2012 Dec 13.

17.

Correlation of perfusion parameters with genes related to angiogenesis regulation in glioblastoma: a feasibility study.

Jain R, Poisson L, Narang J, Scarpace L, Rosenblum ML, Rempel S, Mikkelsen T.

AJNR Am J Neuroradiol. 2012 Aug;33(7):1343-8. doi: 10.3174/ajnr.A2956. Epub 2012 Mar 15.

18.

Integrated morphologic analysis for the identification and characterization of disease subtypes.

Cooper LA, Kong J, Gutman DA, Wang F, Gao J, Appin C, Cholleti S, Pan T, Sharma A, Scarpace L, Mikkelsen T, Kurc T, Moreno CS, Brat DJ, Saltz JH.

J Am Med Inform Assoc. 2012 Mar-Apr;19(2):317-23. doi: 10.1136/amiajnl-2011-000700. Epub 2012 Jan 24.

19.

Prediction of glioblastoma multiform response to bevacizumab treatment using multi-parametric MRI.

Najafi M, Soltanian-Zadeh H, Jafari-Khouzani K, Scarpace L, Mikkelsen T.

PLoS One. 2012;7(1):e29945. doi: 10.1371/journal.pone.0029945. Epub 2012 Jan 11.

20.

Model selection for DCE-T1 studies in glioblastoma.

Bagher-Ebadian H, Jain R, Nejad-Davarani SP, Mikkelsen T, Lu M, Jiang Q, Scarpace L, Arbab AS, Narang J, Soltanian-Zadeh H, Paudyal R, Ewing JR.

Magn Reson Med. 2012 Jul;68(1):241-51. doi: 10.1002/mrm.23211. Epub 2011 Nov 29.

21.

Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.

Narang J, Jain R, Arbab AS, Mikkelsen T, Scarpace L, Rosenblum ML, Hearshen D, Babajani-Feremi A.

Neuro Oncol. 2011 Sep;13(9):1037-46. doi: 10.1093/neuonc/nor075. Epub 2011 Jul 29.

22.

Correlation of immunohistologic and perfusion vascular parameters with MR contrast enhancement using image-guided biopsy specimens in gliomas.

Jain R, Narang J, Gutierrez J, Schultz LR, Scarpace L, Rosenblum M, Mikkelsen T, Rock JP.

Acad Radiol. 2011 Aug;18(8):955-62. doi: 10.1016/j.acra.2011.04.003.

PMID:
21718954
23.

Permeability estimates in histopathology-proved treatment-induced necrosis using perfusion CT: can these add to other perfusion parameters in differentiating from recurrent/progressive tumors?

Jain R, Narang J, Schultz L, Scarpace L, Saksena S, Brown S, Rock JP, Rosenblum M, Gutierrez J, Mikkelsen T.

AJNR Am J Neuroradiol. 2011 Apr;32(4):658-63. doi: 10.3174/ajnr.A2378. Epub 2011 Feb 17.

24.

In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas.

Jain R, Gutierrez J, Narang J, Scarpace L, Schultz LR, Lemke N, Patel SC, Mikkelsen T, Rock JP.

AJNR Am J Neuroradiol. 2011 Feb;32(2):388-94. doi: 10.3174/ajnr.A2280. Epub 2010 Nov 11.

25.

Predicting survival in glioblastomas using diffusion tensor imaging metrics.

Saksena S, Jain R, Narang J, Scarpace L, Schultz LR, Lehman NL, Hearshen D, Patel SC, Mikkelsen T.

J Magn Reson Imaging. 2010 Oct;32(4):788-95. doi: 10.1002/jmri.22304.

PMID:
20882608
26.

Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors.

Narang J, Jain R, Scarpace L, Saksena S, Schultz LR, Rock JP, Rosenblum M, Patel SC, Mikkelsen T.

J Neurooncol. 2011 Apr;102(2):287-93. doi: 10.1007/s11060-010-0317-3. Epub 2010 Aug 1.

PMID:
20680399
27.

Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis.

Rogers LR, Gutierrez J, Scarpace L, Schultz L, Ryu S, Lord B, Movsas B, Honsowetz J, Jain R.

J Neurooncol. 2011 Jan;101(1):25-32. doi: 10.1007/s11060-010-0222-9. Epub 2010 May 20.

PMID:
20490612
28.

Imaging response criteria for recurrent gliomas treated with bevacizumab: role of diffusion weighted imaging as an imaging biomarker.

Jain R, Scarpace LM, Ellika S, Torcuator R, Schultz LR, Hearshen D, Mikkelsen T.

J Neurooncol. 2010 Feb;96(3):423-31. doi: 10.1007/s11060-009-9981-6. Epub 2009 Oct 27.

PMID:
19859666
29.

Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?

Jain R, Ellika S, Lehman NL, Scarpace L, Schultz LR, Rock JP, Rosenblum M, Mikkelsen T.

J Neurooncol. 2010 May;97(3):383-8. doi: 10.1007/s11060-009-0030-2. Epub 2009 Oct 15.

PMID:
19830525
30.

Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade.

Jain R, Ellika SK, Scarpace L, Schultz LR, Rock JP, Gutierrez J, Patel SC, Ewing J, Mikkelsen T.

AJNR Am J Neuroradiol. 2008 Apr;29(4):694-700. doi: 10.3174/ajnr.A0899. Epub 2008 Jan 17.

31.

First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis.

Jain R, Scarpace L, Ellika S, Schultz LR, Rock JP, Rosenblum ML, Patel SC, Lee TY, Mikkelsen T.

Neurosurgery. 2007 Oct;61(4):778-86; discussion 786-7.

PMID:
17986939
32.

Role of perfusion CT in glioma grading and comparison with conventional MR imaging features.

Ellika SK, Jain R, Patel SC, Scarpace L, Schultz LR, Rock JP, Mikkelsen T.

AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1981-7. Epub 2007 Sep 24.

33.

Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis.

Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rosenblum M, Mikkelsen T.

Neurosurgery. 2004 May;54(5):1111-7; discussion 1117-9.

PMID:
15113465
34.

Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.

Rock JP, Hearshen D, Scarpace L, Croteau D, Gutierrez J, Fisher JL, Rosenblum ML, Mikkelsen T.

Neurosurgery. 2002 Oct;51(4):912-9; discussion 919-20.

PMID:
12234397
35.
36.

The chemical nature of the microelectronics industry.

Rohm T, Scarpace L, Fluer L.

Occup Med. 1986 Jan-Mar;1(1):13-34. Review.

PMID:
3299769

Supplemental Content

Loading ...
Support Center